![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Springe zu: 2017
Anzahl der Publikationen: 2
2017
Vomacka, Lena; Albert, Nathalie L. 
ORCID: https://orcid.org/0000-0003-0953-7624; Lindner, Simon; Unterrainer, Marcus; Mahler, Christoph; Brendel, Matthias; Ermoschkin, Larissa; Gosewisch, Astrid; Brunegraf, Anika; Buckley, Christopher; Kümpfel, Tania; Rupprecht, Rainer; Ziegler, Sibylle; Kerschensteiner, Martin; Bartenstein, Peter und Böning, Guido
(2017):
TSPO imaging using the novel PET ligand [F-18]GE-180: quantification approaches in patients with multiple sclerosis.
In: EJNMMI Research, Bd. 7, 89
[PDF, 2MB]
ORCID: https://orcid.org/0000-0003-0953-7624; Lindner, Simon; Unterrainer, Marcus; Mahler, Christoph; Brendel, Matthias; Ermoschkin, Larissa; Gosewisch, Astrid; Brunegraf, Anika; Buckley, Christopher; Kümpfel, Tania; Rupprecht, Rainer; Ziegler, Sibylle; Kerschensteiner, Martin; Bartenstein, Peter und Böning, Guido
(2017):
TSPO imaging using the novel PET ligand [F-18]GE-180: quantification approaches in patients with multiple sclerosis.
In: EJNMMI Research, Bd. 7, 89
[PDF, 2MB]
Vomacka, Lena; Albert, Nathalie L. ORCID: https://orcid.org/0000-0003-0953-7624; Lindner, Simon; Unterrainer, Marcus; Mahler, Christoph; Brendel, Matthias; Ermoschkin, Larissa; Gosewisch, Astrid; Brunegraf, Anika; Kmpfel, Tania; Kerschensteiner, Martin; Bartenstein, Peter und Böning, Guido
(2017):
Quantification of the new TSPO ligand [F-18]GE-180 in patients with multiple sclerosis - initial results.
In: Journal of Nuclear Medicine, Bd. 58
ORCID: https://orcid.org/0000-0003-0953-7624; Lindner, Simon; Unterrainer, Marcus; Mahler, Christoph; Brendel, Matthias; Ermoschkin, Larissa; Gosewisch, Astrid; Brunegraf, Anika; Kmpfel, Tania; Kerschensteiner, Martin; Bartenstein, Peter und Böning, Guido
(2017):
Quantification of the new TSPO ligand [F-18]GE-180 in patients with multiple sclerosis - initial results.
In: Journal of Nuclear Medicine, Bd. 58